SAN DIEGO, Calif., April 19 /PRNewswire/ -- Cadence Pharmaceuticals, Inc., a hospital-focused biopharmaceutical company, today announced that Ted Schroeder, President and Chief Executive Officer of Cadence Pharmaceuticals, is scheduled to present a corporate overview on Monday, April 24, 2006 at 11:00 a.m. Eastern Time at the UBS Global Specialty Pharmaceuticals Conference. The presentation will be held at the Grand Hyatt Hotel in New York, NY.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals, Inc. is a San Diego-based biopharmaceutical company focused on the development and commercialization of therapeutics utilized primarily in the hospital setting. The business of Cadence is driven by in-licensing and acquisition of late-stage development compounds and commercial-stage drugs. Cadence currently has two Phase III products in development for the treatment of post-operative pain and the prevention of catheter-related infections.
For more information, contact Ted Schroeder, President and CEO, at 858-436-1400, or visit our website at www.cadencepharm.com.
Cadence Pharmaceuticals, Inc.
CONTACT: Ted Schroeder, President and CEO of Cadence Pharmaceuticals,Inc., +1-858-436-1400
Web site: http://www.cadencepharm.com/
